Clinical Trials Browser

Phase 1/2 × OTHER_GOV × apatinib × Clear all

NCT05019690 2024-09-19

Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer

Phase 1/2 Recruiting

Advanced Triple Negative Breast Cancer

NCT03599778 2018-07-26

XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma

Phase 1/2 Unknown

Gastrointestinal

Stomach Neoplasms